Intravenous ferric carboxymaltose in heart failure with iron deficiency

19 May 2025 (14:05 - 14:15)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Mahir Karakas

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

6 More presentations in this session

Presentation thumbnail

Discussant panel

Presentation thumbnail

Effects of finerenone on readmissions for heart failure: a prespecified secondary analysis of the FINEARTS-HF trial

Doctor A. Bhatt (San Francisco, US)

Presentation thumbnail

Trade-off of risk and benefit of finerenone across the spectrum of kidney function in patients with heart failure with mildly reduced and preserved ejection fraction in the FINEARTS-HF trial

Doctor S. Chatur (Boston, US)

Presentation thumbnail

Efficacy of intravenous iron for the treatment of heart failure varies by method of meta-analysis: a Bayesian and frequentist reappraisal of the evidence

Doctor A. Henderson (Glasgow, GB)

Presentation thumbnail

The effect of omecamtiv mecarbil on outcomes analysed using the win ratio: an exploratory analysis of GALACTIC-HF

Doctor K. Docherty (Glasgow, GB)

Access the full session

Session thumbnail

Clinical trials updates in medical therapy

The Event

Event poster

Heart Failure 2025

19 May 2025 14:05 CET

You may be interested in

Congress Presentation

FAIR-HF2 DZHK05: Efficacy of ferric carboxymaltose in heart failure and iron deficiency stratified by transferrin saturation

Congress Presentation

Discussant review - FAIR-HF2 DZHK05

Congress Presentation

Intravenous iron for patients with heart failure – the accumulated evidence

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources